LEADERS IN ONCOLOGY CARE LIMITED

• ◆

  1 PSC ceased in last 24 months

  Significant control changed hands — see the Ownership section.

Accounting basis

FRS 102

Reporting scope

Standalone (parent only)

Auditor

Ernst & Young LLP

Audit opinion

Unqualified (clean)

Going concern

Affirmed

“These financial statements have been prepared on a going concern basis and no material uncertainties that cast significant doubt about the ability of the company to continue as a going concern have been identified by the directors. HCA UK Holdings Limited ('HCA UK') as an organisation manages its cash position centrally, providing access to funding for all its subsidiaries as and when required. Leaders in Oncology Care Limited is a subsidiary within the HCA UK group. As cash is managed centrally, the directors have considered the going concern assessment for the HCA UK group of entities collectively. HCA UK group has seen very strong cash flow throughout 2024 and has no external debt within the UK group, with a cash balance of £66m at the end of December 2024. In addition to this, HCA Healthcare Inc., the ultimate parent company, have confirmed, via a letter of support their intention to provide financial support, if necessary, to the HCA UK Group until 31 December 2026.”

Group structure

1. LEADERS IN ONCOLOGY CARE LIMITED · parent
   1. LOC @ London Bridge Hospital LLP 92.22% · England · Provision of healthcare services
   2. PET CT LLP 100% · England · Provision of healthcare services
   3. LOC Partnership LLP 94.95% · England · Provision of healthcare services
   4. LOC @ Chelsea LLP 76.8% · England · Provision of healthcare services

Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers

Filings

2

last 12 months

Capital events

0

last 24 months

Officers appointed

0

last 12 months

Officers resigned

0

last 12 months

Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.